Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Pediatr Hematol Oncol. 2023 Mar;40(2):192-195. doi: 10.1080/08880018.2022.2095473. Epub 2022 Jul 4.
The COVID-19 pandemic has had a huge effect all over the world and its impact has been even more profound in the world of Healthcare. In this brief report we'd like to report about our experience in pediatric newly diagnosed thrombocytopenia and how we have seen the landscape of this disease change in the last 2 years. In particular, we believe that the use of personal protective equipment and lockdown measures have reduced the incidence of viral triggers that are supposed to be responsible for the vast majority of ITP cases. Along with these data, we found some other significant differences in the period taken into account.
新冠疫情对全球造成了巨大影响，对医疗保健领域的影响更为深远。在这份简短的报告中，我们将介绍我们在儿科新诊断出的血小板减少症方面的经验，以及过去 2 年来我们如何看到这种疾病的变化。特别是，我们认为个人防护设备和封锁措施的使用降低了导致绝大多数 ITP 病例的病毒触发因素的发生率。随着这些数据，我们还发现了所考虑时间段中的一些其他显著差异。
